Cancer Biotherapy and Radiopharmaceuticals

Impact Factor: 2.4

Coeditors-in-Chief: Ekaterina Dadachova, PhD

Description:

Cancer Biotherapy and Radiopharmaceuticals provides peer-reviewed research on cutting-edge therapeutic investigations and advancements in all aspects of radioligand therapy for treating cancer and other conditions.